Mozambique Introduces Lenacapavir and New HIV Prevention Guidelines
Mozambique has introduced Lenacapavir, a long-acting injectable drug for HIV pre-exposure prophylaxis (PrEP), alongside new national biomedical prevention guidelines covering
Read More